Baltimore, MD, United States of America

Theresa Zhang

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Theresa Zhang

Introduction

Theresa Zhang is an innovative inventor based in Baltimore, MD. She has made significant contributions to the field of cancer immunology, focusing on the identification and prioritization of mutation-derived neoantigens. With two patents to her name, her work showcases the potential for transformative advancements in cancer treatment.

Latest Patents

Theresa's latest patents revolve around methods and systems designed for the effective identification and prioritization of neoantigens. Cancer immunology presents promising avenues for treatment; however, the validation of potential neoantigens is often prohibitively expensive and complex. Her innovations leverage analysis of MHC binding affinity, antigen processing, and a variety of other factors, allowing for the efficient screening of candidate neoantigens using sequencing data. These methodologies aim to save both time and financial resources by streamlining the process of identifying priority candidates for further experimental validation.

Career Highlights

Theresa Zhang has demonstrated an impressive career trajectory at Personal Genome Diagnostics, Inc., where she actively contributes to pioneering research in genomic medicine. Her work is crucial in advancing our understanding of neoantigens and their applicability in targeted cancer therapies. The methodologies developed under her patents are set to enhance the validation process, making cancer treatments more accessible and effective.

Collaborations

Throughout her career, Theresa has collaborated with notable colleagues, including James Robert White and Victor E Velculescu. These partnerships amplify her impact in the field, leading to cutting-edge innovations in cancer immunology.

Conclusion

Theresa Zhang is a formidable force in the realm of cancer research and innovation. Her dedication to developing efficient methods for neoantigen prioritization not only represents her commitment to scientific advancement but also holds the promise of improved treatment options for cancer patients worldwide. With her expertise and groundbreaking patents, Theresa is certainly an inventor to watch in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…